Clinical trial

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

NCT01648231

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-08-06

PhasePHASE1

Study timeline

Study start (actual)2012-08-06Date precision: day

Registry last updated2017-07-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

Reference Treatment: 1 x 5mg amlodipine tablet and 1 x 100mg losartan tablet administered in fasted stateDRUG

Fixed Dose Combination 1: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted stateDRUG

Fixed Dose Combination 2: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted stateDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01648231 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.